- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02832804
Effect of Transcranial Direct-current Stimulation Therapy on Primary Chronic Insomnia Patients
September 23, 2021 updated by: Ki-Young Jung, Seoul National University Hospital
Effect of Transcranial Direct-current Stimulation Therapy on Primary Chronic Insomnia Patients: A Pilot Study.Insomnia Patients
To evaluate the clinical efficacy and safety of neuromodulation by transcranial direct current stimulation (tDCS) in the patients with primary chronic insomnia .
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
visit 1
- to fill in a questionnaire (Clinical Global Impression, CGI; Leeds Sleep Evaluation Questionnaire, LSEQ; Stanford Sleepiness Scale, SSS; Hospital Anxiety and Depression Scale, HADS; 36-Item Short Form Survey, SF-36)
- EEG
visit 2-6
- tDCS stimulation (monday ~ friday)
- anodal / cathodal / sham
- to fill in a questionnaire (CGI, LSEQ, SSS, HADS)
- analysis the results of sleep log and actigraphy
visit 7 : 1 week after treatment
- to fill in a questionnaire (CGI, LSEQ, SSS, HADS)
- analysis the results of sleep log and actigraphy
- EEG
visit 8 : 1 month after treatment
- to fill in a questionnaire (CGI, LSEQ, SSS, HADS, SF-36)
- analysis the results of sleep log
Study Type
Interventional
Enrollment (Actual)
8
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Seoul, Korea, Republic of
- Seoul National University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
19 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- adult (older than 19 years)
- primary insomnia
- right handed
- agree with participation of this study
Exclusion Criteria:
- diagnosed with epilepsy or history of seizure
- change of antipsychotic drug within 1 month
- under suspicion of sleep apnea or periodic limb movement disorder
- mental retardation (IQ < 70)
- pregnant woman
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: anodal stimulation
10 person The patients treated by anodal stimulation (2mA) for 20 minutes
|
Experimental: anodal stimulation (2mA) for 20 minutes Active Comparator: cathodal stimulation (2mA) for 20 minutes Sham Comparator: sham stimulation (2mA) for 15 seconds
Other Names:
|
|
Active Comparator: cathodal stimulation
10 person The patients treated by cathodal stimulation (1-2mA) for 20 minutes
|
Experimental: anodal stimulation (2mA) for 20 minutes Active Comparator: cathodal stimulation (2mA) for 20 minutes Sham Comparator: sham stimulation (2mA) for 15 seconds
Other Names:
|
|
Sham Comparator: sham stimulation
10 person The patients treated by anodal stimulation (1-2mA) for 15 seconds
|
Experimental: anodal stimulation (2mA) for 20 minutes Active Comparator: cathodal stimulation (2mA) for 20 minutes Sham Comparator: sham stimulation (2mA) for 15 seconds
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
sleep log and actiwatch
Time Frame: Change from baseline at 1 week
|
Changes of sleep quality
|
Change from baseline at 1 week
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
questionnaire
Time Frame: Change from baseline at 1 month
|
Change from baseline at 1 month
|
|
EEG spectrum analysis
Time Frame: Change from baseline at 1 month
|
Change from baseline at 1 month
|
|
Number of Participants with Adverse Events as a Measure of Safety and Tolerability
Time Frame: Change from baseline at 1 month
|
Change from baseline at 1 month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Chair: Ki-Young Jung, professor, Seoul National University Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 1, 2016
Primary Completion (Actual)
September 30, 2016
Study Completion (Actual)
May 1, 2017
Study Registration Dates
First Submitted
April 18, 2016
First Submitted That Met QC Criteria
July 11, 2016
First Posted (Estimate)
July 14, 2016
Study Record Updates
Last Update Posted (Actual)
September 24, 2021
Last Update Submitted That Met QC Criteria
September 23, 2021
Last Verified
September 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1509-061-703
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Primary Insomnia
-
Christoph NissenRecruitingInsomnia | Insomnia Chronic | Insomnia Disorder | Insomnia, Primary | Insomnia Type; Sleep Disorder | Insomnia Disorders | Insomnia, NonorganicSwitzerland
-
Midnight Pharma, LLCCompletedChronic Primary InsomniaUnited States
-
IWK Health CentreCompletedPrimary Insomnia | Nonorganic InsomniaCanada
-
Oregon Health and Science UniversityCompletedPrimary Insomnia | Psychophysiological InsomniaUnited States
-
University of RochesterSanofi-SynthelaboCompletedInsomnia | Primary Insomnia | Psychophysiologic InsomniaUnited States
-
US Department of Veterans AffairsCompletedInsomnia | Primary Insomnia | Secondary InsomniaUnited States
-
University of UtahEvans Army Community HospitalCompletedPrimary Insomnia | Secondary InsomniaUnited States
-
University of WashingtonUnknownChronic Insomnia | Insomnia, Primary
-
Jack Edinger, PhDMerck Sharp & Dohme LLCCompletedInsomnia | Primary Insomnia | Chronic InsomniaUnited States
-
University of PittsburghCompletedInsomnia Chronic | Insomnia, PrimaryUnited States
Clinical Trials on transcranial Direct Current Stimulation
-
National Taiwan University HospitalRecruitingStroke | Brain Connectivity | Transcranial Direct Current Stimulation | Motor Learning | Adaptation | Brain Structure | AnkleTaiwan
-
Medical University of South CarolinaEunice Kennedy Shriver National Institute of Child Health and Human Development...Withdrawn
-
Federal University of ParaíbaCompleted
-
Shirley Ryan AbilityLabNational Institute on Deafness and Other Communication Disorders (NIDCD)CompletedStroke | Nonfluent AphasiaUnited States
-
University of Campinas, BrazilUnknownEpilepsy IntractableBrazil
-
University of Texas Rio Grande ValleyActive, not recruitingSpinal Cord Diseases | Spinal Cord InjuriesUnited States
-
Dina Hatem ElhammadyUnknown
-
Beijing Sport UniversityNot yet recruitingTranscranial Direct Current Stimulation (tDCS)
-
Federal University of ParaíbaUnknown
-
WANG KAICompletedChronic Insomnia | Transcranial Direct Current StimulationChina